These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


846 related items for PubMed ID: 29280968

  • 21. Structure-activity relationships and antiproliferative effects of 1,2,3,4-4H-quinoxaline derivatives as tubulin polymerization inhibitors.
    Liang T, Zhou X, Lu L, Dong H, Zhang Y, Xu Y, Qi J, Zhang Y, Wang J.
    Bioorg Chem; 2021 May; 110():104793. PubMed ID: 33770673
    [Abstract] [Full Text] [Related]

  • 22. Novel HDAC/Tubulin Dual Inhibitor: Design, Synthesis and Docking Studies of α-Phthalimido-Chalcone Hybrids as Potential Anticancer Agents with Apoptosis-Inducing Activity.
    Mourad AAE, Mourad MAE, Jones PG.
    Drug Des Devel Ther; 2020 May; 14():3111-3130. PubMed ID: 32848361
    [Abstract] [Full Text] [Related]

  • 23. Synthesis, biological evaluation and molecular docking studies of aminochalcone derivatives as potential anticancer agents by targeting tubulin colchicine binding site.
    Wang G, Peng Z, Zhang J, Qiu J, Xie Z, Gong Z.
    Bioorg Chem; 2018 Aug; 78():332-340. PubMed ID: 29627654
    [Abstract] [Full Text] [Related]

  • 24. Synthesis of phenstatin/isocombretastatin-chalcone conjugates as potent tubulin polymerization inhibitors and mitochondrial apoptotic inducers.
    Kamal A, Kumar GB, Vishnuvardhan MV, Shaik AB, Reddy VS, Mahesh R, Sayeeda IB, Kapure JS.
    Org Biomol Chem; 2015 Apr 07; 13(13):3963-81. PubMed ID: 25721862
    [Abstract] [Full Text] [Related]

  • 25. Synthesis, biological evaluation, and molecular modelling of new naphthalene-chalcone derivatives as potential anticancer agents on MCF-7 breast cancer cells by targeting tubulin colchicine binding site.
    Wang G, Liu W, Gong Z, Huang Y, Li Y, Peng Z.
    J Enzyme Inhib Med Chem; 2020 Dec 07; 35(1):139-144. PubMed ID: 31724435
    [Abstract] [Full Text] [Related]

  • 26. Development of adamantane scaffold containing 1,3,4-thiadiazole derivatives: Design, synthesis, anti-proliferative activity and molecular docking study targeting EGFR.
    Wassel MMS, Ammar YA, Elhag Ali GAM, Belal A, Mehany ABM, Ragab A.
    Bioorg Chem; 2021 May 07; 110():104794. PubMed ID: 33735711
    [Abstract] [Full Text] [Related]

  • 27. Synthesis, Evaluation for Cytotoxicity and Molecular Docking Studies of Benzo[c]furan-Chalcones for Potential to Inhibit Tubulin Polymerization and/or EGFR-Tyrosine Kinase Phosphorylation.
    Mphahlele MJ, Maluleka MM, Parbhoo N, Malindisa ST.
    Int J Mol Sci; 2018 Aug 28; 19(9):. PubMed ID: 30154363
    [Abstract] [Full Text] [Related]

  • 28. Novel 1,2,4-triazole derivatives as potential anticancer agents: Design, synthesis, molecular docking and mechanistic studies.
    El-Sherief HAM, Youssif BGM, Bukhari SNA, Abdel-Aziz M, Abdel-Rahman HM.
    Bioorg Chem; 2018 Feb 28; 76():314-325. PubMed ID: 29227915
    [Abstract] [Full Text] [Related]

  • 29. Introducing of acyclonucleoside analogues tethered 1,2,4-triazole as anticancer agents with dual epidermal growth factor receptor kinase and microtubule inhibitors.
    Aouad MR, Al-Mohammadi HM, Al-Blewi FF, Ihmaid S, Elbadawy HM, Althagfan SS, Rezki N.
    Bioorg Chem; 2020 Jan 28; 94():103446. PubMed ID: 31791685
    [Abstract] [Full Text] [Related]

  • 30. Design, synthesis and biological evaluation of flexible and rigid analogs of 4H-1,2,4-triazoles bearing 3,4,5-trimethoxyphenyl moiety as new antiproliferative agents.
    Ansari M, Shokrzadeh M, Karima S, Rajaei S, Hashemi SM, Mirzaei H, Fallah M, Emami S.
    Bioorg Chem; 2019 Dec 28; 93():103300. PubMed ID: 31586708
    [Abstract] [Full Text] [Related]

  • 31. Design, synthesis and cytotoxic activity of certain novel chalcone analogous compounds.
    El-Meligie S, Taher AT, Kamal AM, Youssef A.
    Eur J Med Chem; 2017 Jan 27; 126():52-60. PubMed ID: 27744186
    [Abstract] [Full Text] [Related]

  • 32. Design, synthesis and biological evaluation of indole-based [1,2,4]triazolo[4,3-a] pyridine derivatives as novel microtubule polymerization inhibitors.
    Wu CJ, Wu JQ, Hu Y, Pu S, Lin Y, Zeng Z, Hu J, Chen WH.
    Eur J Med Chem; 2021 Nov 05; 223():113629. PubMed ID: 34175541
    [Abstract] [Full Text] [Related]

  • 33. Novel Aldimine-Type Schiff Bases of 4-Amino-5-[(3,4,5-trimethoxyphenyl)methyl]-1,2,4-triazole-3-thione/thiol: Docking Study, Synthesis, Biological Evaluation, and Anti-Tubulin Activity.
    Ameri A, Khodarahmi G, Hassanzadeh F, Forootanfar H, Hakimelahi GH.
    Arch Pharm (Weinheim); 2016 Aug 05; 349(8):662-81. PubMed ID: 27320785
    [Abstract] [Full Text] [Related]

  • 34. Quinazolinone-Amino Acid Hybrids as Dual Inhibitors of EGFR Kinase and Tubulin Polymerization.
    Zayed MF, Rateb HS, Ahmed S, Khaled OA, Ibrahim SRM.
    Molecules; 2018 Jul 12; 23(7):. PubMed ID: 30002297
    [Abstract] [Full Text] [Related]

  • 35. Identification of new [1,2,4]triazolo[4,3-a]quinoxalines as potent VEGFR-2 tyrosine kinase inhibitors: Design, synthesis, anticancer evaluation, and in silico studies.
    Alsaif NA, Taghour MS, Alanazi MM, Obaidullah AJ, Alanazi WA, Alasmari A, Albassam H, Dahab MA, Mahdy HA.
    Bioorg Med Chem; 2021 Sep 15; 46():116384. PubMed ID: 34479065
    [Abstract] [Full Text] [Related]

  • 36. Design and synthesis of imidazo[2,1-b]thiazole-chalcone conjugates: microtubule-destabilizing agents.
    Kamal A, Balakrishna M, Nayak VL, Shaik TB, Faazil S, Nimbarte VD.
    ChemMedChem; 2014 Dec 15; 9(12):2766-80. PubMed ID: 25313981
    [Abstract] [Full Text] [Related]

  • 37. Synthesis, molecular modeling and biological evaluation of guanidine derivatives as novel antitubulin agents.
    Qian Y, Zhang HJ, Lv PC, Zhu HL.
    Bioorg Med Chem; 2010 Dec 01; 18(23):8218-25. PubMed ID: 21036623
    [Abstract] [Full Text] [Related]

  • 38. Synthesis of benzo[d]imidazo[2,1-b]thiazole-chalcone conjugates as microtubule targeting and apoptosis inducing agents.
    Sultana F, Reddy Bonam S, Reddy VG, Nayak VL, Akunuri R, Rani Routhu S, Alarifi A, Halmuthur MSK, Kamal A.
    Bioorg Chem; 2018 Feb 01; 76():1-12. PubMed ID: 29102724
    [Abstract] [Full Text] [Related]

  • 39. Hybrid Pharmacophore Design, Molecular Docking, Synthesis, and Biological Evaluation of Novel Aldimine-Type Schiff Base Derivatives as Tubulin Polymerization Inhibitor.
    Ameri A, Khodarahmi G, Forootanfar H, Hassanzadeh F, Hakimelahi GH.
    Chem Biodivers; 2018 Mar 01; 15(3):e1700518. PubMed ID: 29292595
    [Abstract] [Full Text] [Related]

  • 40. Design, synthesis and biological evaluation of novel pyrazoline-containing derivatives as potential tubulin assembling inhibitors.
    Qin YJ, Li YJ, Jiang AQ, Yang MR, Zhu QZ, Dong H, Zhu HL.
    Eur J Med Chem; 2015 Apr 13; 94():447-57. PubMed ID: 25828827
    [Abstract] [Full Text] [Related]


    Page: [Previous] [Next] [New Search]
    of 43.